Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.

Urology

Volumn 54, Issue 6, 1999, Pages 1058-1063

  Manyak, M J ^a   Hinkle, G H ^a   Olsen, J O ^a   Chiaccherini, R P ^a   Partin, A W ^a   Piantadosi, S ^a   Burgers, J K ^a   Texter, J H ^a   Neal, C E ^a   Libertino, J A ^a   Wright Jr , G L ^a   Maguire, R T ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPROMAB PENDETIDE; DIAGNOSTIC AGENT; INDIUM; MONOCLONAL ANTIBODY;

ADENOCARCINOMA; AGED; ALGORITHM; ARTICLE; CLINICAL TRIAL; HUMAN; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDY; PROSTATE TUMOR; RADIOIMMUNOASSAY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADENOCARCINOMA; AGED; ALGORITHMS; ANTIBODIES, MONOCLONAL; HUMANS; INDIUM RADIOISOTOPES; LOGISTIC MODELS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOIMMUNODETECTION; SENSITIVITY AND SPECIFICITY;

MLCS; MLOWN;

EID: 0033253008     PISSN: None     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/s0090-4295(99)00314-3     Document Type: Article

References (0)